Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2025

Nov 5, 2025

31971_dirs_2025-11-05_7f617105-ce02-4f38-aee7-2a6efee92943.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-11-04

Reporting Person: Foust Hollie K (General Counsel & Corp Sec)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-04 Common Stock M 4000 Acquired 4000 Direct
2025-11-04 Common Stock F 1114 $45.71 Disposed 2886 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-11-04 RSUs (Restricted Stock Units) $ M 4000 Disposed Common Stock (4000) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").

F2: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 50% vesting after year 1 and 50% vesting after year 2.